Geode Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187M | Sell |
|
|||||
|
2025
Q1 | $190M | Buy |
|
|||||
|
2024
Q4 | $227M | Buy |
|
|||||
|
2024
Q3 | $239M | Buy |
|
|||||
|
2024
Q2 | $251M | Buy |
|
|||||
|
2024
Q1 | $320M | Buy |
|
|||||
|
2023
Q4 | $270M | Buy |
|
|||||
|
2023
Q3 | $220M | Buy |
|
|||||
|
2023
Q2 | $231M | Buy |
|
|||||
|
2023
Q1 | $214M | Buy |
|
|||||
|
2022
Q4 | $226M | Buy |
|
|||||
|
2022
Q3 | $196M | Buy |
|
|||||
|
2022
Q2 | $207M | Buy |
|
|||||
|
2022
Q1 | $272M | Buy |
|
|||||
|
2021
Q4 | $348M | Buy |
|
|||||
|
2021
Q3 | $375M | Buy |
|
|||||
|
2021
Q2 | $323M | Buy |
|
|||||
|
2021
Q1 | $171M | Buy |
|
|||||
|
2020
Q4 | $141M | Buy |
|
|||||
|
2020
Q3 | $120M | Sell |
|
|||||
|
2020
Q2 | $96.8M | Buy |
|
|||||
|
2020
Q1 | $68M | Buy |
|
|||||
|
2019
Q4 | $79.6M | Buy |
|
|||||
|
2019
Q3 | $66.1M | Buy |
|
|||||
|
2019
Q2 | $69.6M | Buy |
|
|||||
|
2019
Q1 | $69.2M | Buy |
|
|||||
|
2018
Q4 | $51.8M | Buy |
|
|||||
|
2018
Q3 | $57.7M | Buy |
|
|||||
|
2018
Q2 | $47.6M | Sell |
|
|||||
|
2018
Q1 | $46.2M | Buy |
|
|||||
|
2017
Q4 | $47.3M | Buy |
|
|||||
|
2017
Q3 | $43.7M | Buy |
|
|||||
|
2017
Q2 | $38M | Buy |
|
|||||
|
2017
Q1 | $33.3M | Buy |
|
|||||
|
2016
Q4 | $25.9M | Buy |
|
|||||
|
2016
Q3 | $27.2M | Buy |
|
|||||
|
2016
Q2 | $25.7M | Buy |
|
|||||
|
2016
Q1 | $23K | Buy |
|
|||||
|
2015
Q4 | $21.8M | Sell |
|
|||||
|
2015
Q3 | $17.2M | Buy |
|
|||||
|
2015
Q2 | $18.2M | Sell |
|
|||||
|
2015
Q1 | $20.6M | Buy |
|
|||||
|
2014
Q4 | $15.6M | Sell |
|
|||||
|
2014
Q3 | $15.4M | Sell |
|
|||||
|
2014
Q2 | $13.8M | Buy |
|
|||||
|
2014
Q1 | $14.3M | Buy |
|
|||||
|
2013
Q4 | $11.6M | Buy |
|
|||||
|
2013
Q3 | $9.1M | Buy |
|
|||||
|
2013
Q2 | $7.68M | Buy |
|